Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma
Conditions: Esophageal Cancer; Surgery; Neoadjuvant Treatment; Survival Intervention: Drug: Neoadjuvant immunochemotherapy Sponsor: Henan Cancer Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Esophagus Cancer | Hospitals | Research